Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$20.71 - $51.02 $2.02 Million - $4.97 Million
-97,340 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$21.84 - $44.0 $2.13 Million - $4.28 Million
97,340 New
97,340 $3.56 Million
Q3 2020

Nov 16, 2020

SELL
$13.63 - $24.12 $280,778 - $496,872
-20,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.65 - $14.11 $157,590 - $290,666
20,600 New
20,600 $267,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $221M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.